SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sunil Healthcare features among FT 1000 High-Growth Companies in Asia Pacific

14 May 2018 Evaluate

Sunil Healthcare has been ranked at 635th position among 1000 High Growth Companies in Asia-Pacific 2018 with 76% growth in Revenue and 20.7% CAGR during 2013 to 2016.

The study was conducted by the Financial Times research Partner Statista. The inaugural FT 1000 High-Growth Companies Asia-Pacific list considered companies based in 11 of the region’s more developed markets. The companies have been ranked according to the percentage growth in their revenues between 2013 and 2016.

Sunil Healthcare, having started its operations over three decades ago, is the second largest manufacturer of EHGC in India and enjoys immense credibility in various global markets.


Sunil Healthcare Share Price

65.40 1.20 (1.87%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×